Boji Medical Technology Co.,Ltd.

Equities

300404

CNE100001Y00

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
7.31 CNY +0.55% Intraday chart for Boji Medical Technology Co.,Ltd. +9.76% -18.32%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023 CI
Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Boji Medical Technology Inks 70 Million Yuan Technical Services Deal With Ruianbo Pharmaceutical Technology MT
Boji Medical Technology's Unit Gets Nod to Market Erectile Dysfunction Tablets MT
Tranche Update on Boji Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024. CI
Boji Medical Technology Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has closed with 2,667,000 shares, representing 0.72% for CNY 15.10 million. CI
Boji Medical Technology Bags 107.7 Million Yuan Clinical Trial Assistance Deal; Shares Surge 20% MT
Boji Medical Technology Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares. CI
Boji Medical Technology Co., Ltd. authorizes a Buyback Plan. CI
Boji Medical Scores 54 Million Yuan Contract For Eye Drop Clinical Trial Research MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors CI
Boji Medical Technology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023 CI
Boji Medical Technology Co., Ltd. Proposes Cash Dividend for 2022 CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Boji Medical Technology Gets Warning for Disclosure Breaches; Shares Jump 7% MT
Boji Medical’s Chairman to Boost Stake to 39% After 84 Million Yuan Deal; Shares Rally 14% MT
Boji Medical Technology Co., Ltd. announced that it expects to receive CNY 83.999999 million in funding CI
Boji Medical Signs 55.5 Million Yuan Deal to Complete Trial of Therapeutic Drug MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Boji Medical Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 02 June 2022 CI
Boji CRO Approves Cash Dividend for the Year 2021 CI
Boji Medical Technology Co., Ltd. Proposes Final Cash Dividend for 2021 CI
Chart Boji Medical Technology Co.,Ltd.
More charts
Boji Medical Technology Co Ltd is a China-based company that provides Contract Research Organization (CRO) services. The Company mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The Company's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The Company mainly conducts its businesses in the domestic market.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300404 Stock
  4. News Boji Medical Technology Co.,Ltd.
  5. Boji Medical Signs 55.5 Million Yuan Deal to Complete Trial of Therapeutic Drug